Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
44.24
-0.99 (-2.19%)
At close: Apr 28, 2026, 4:00 PM EDT
44.25
+0.01 (0.02%)
After-hours: Apr 28, 2026, 7:44 PM EDT
Medline Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Medline stock have an average target of 50.48, with a low estimate of 40 and a high estimate of 60. The average target predicts an increase of 14.10% from the current stock price of 44.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 11, 2026.
Analyst Ratings
The average analyst rating for Medline stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 |
| Buy | 12 | 12 | 12 | 12 |
| Hold | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 22 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +35.62% | Mar 11, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | +19.80% | Mar 10, 2026 |
| Tigress Financial | Tigress Financial | Strong Buy Maintains $55 → $60 | Strong Buy | Maintains | $55 → $60 | +35.62% | Mar 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +24.32% | Mar 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +17.54% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
31.53B
from 28.43B
Increased by 10.88%
Revenue Next Year
33.95B
from 31.53B
Increased by 7.69%
EPS This Year
1.50
from 1.43
Increased by 4.82%
EPS Next Year
1.69
from 1.50
Increased by 13.01%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.7B | 35.6B | |||
| Avg | 31.5B | 33.9B | |||
| Low | 30.1B | 32.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.9% | 12.9% | |||
| Avg | 10.9% | 7.7% | |||
| Low | 5.8% | 2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.65 | 1.92 | |||
| Avg | 1.50 | 1.69 | |||
| Low | 1.36 | 1.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.2% | 28.1% | |||
| Avg | 4.8% | 13.0% | |||
| Low | -4.8% | 1.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.